Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Nature ; 566(7745): 548-552, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-30760924

RESUMEN

Singlet molecular oxygen (1O2) has well-established roles in photosynthetic plants, bacteria and fungi1-3, but not in mammals. Chemically generated 1O2 oxidizes the amino acid tryptophan to precursors of a key metabolite called N-formylkynurenine4, whereas enzymatic oxidation of tryptophan to N-formylkynurenine is catalysed by a family of dioxygenases, including indoleamine 2,3-dioxygenase 15. Under inflammatory conditions, this haem-containing enzyme is expressed in arterial endothelial cells, where it contributes to the regulation of blood pressure6. However, whether indoleamine 2,3-dioxygenase 1 forms 1O2 and whether this contributes to blood pressure control have remained unknown. Here we show that arterial indoleamine 2,3-dioxygenase 1 regulates blood pressure via formation of 1O2. We observed that in the presence of hydrogen peroxide, the enzyme generates 1O2 and that this is associated with the stereoselective oxidation of L-tryptophan to a tricyclic hydroperoxide via a previously unrecognized oxidative activation of the dioxygenase activity. The tryptophan-derived hydroperoxide acts in vivo as a signalling molecule, inducing arterial relaxation and decreasing blood pressure; this activity is dependent on Cys42 of protein kinase G1α. Our findings demonstrate a pathophysiological role for 1O2 in mammals through formation of an amino acid-derived hydroperoxide that regulates vascular tone and blood pressure under inflammatory conditions.


Asunto(s)
Presión Sanguínea/fisiología , Inflamación/sangre , Inflamación/fisiopatología , Oxígeno Singlete/metabolismo , Vasodilatadores/metabolismo , Animales , Línea Celular , Proteína Quinasa Dependiente de GMP Cíclico Tipo I/antagonistas & inhibidores , Proteína Quinasa Dependiente de GMP Cíclico Tipo I/química , Proteína Quinasa Dependiente de GMP Cíclico Tipo I/metabolismo , Cisteína/metabolismo , Activación Enzimática/efectos de los fármacos , Femenino , Humanos , Peróxido de Hidrógeno/química , Peróxido de Hidrógeno/metabolismo , Peróxido de Hidrógeno/farmacología , Indolamina-Pirrol 2,3,-Dioxigenasa/química , Indolamina-Pirrol 2,3,-Dioxigenasa/metabolismo , Inflamación/enzimología , Masculino , Oxidación-Reducción/efectos de los fármacos , Ratas , Transducción de Señal , Oxígeno Singlete/química , Triptófano/química , Triptófano/metabolismo
2.
J Biol Chem ; 291(33): 17427-36, 2016 08 12.
Artículo en Inglés | MEDLINE | ID: mdl-27342776

RESUMEN

Phosphodiesterase 5 (PDE5) inhibitors limit myocardial injury caused by stresses, including doxorubicin chemotherapy. cGMP binding to PKG Iα attenuates oxidant-induced disulfide formation. Because PDE5 inhibition elevates cGMP and protects from doxorubicin-induced injury, we reasoned that this may be because it limits PKG Iα disulfide formation. To investigate the role of PKG Iα disulfide dimerization in the development of apoptosis, doxorubicin-induced cardiomyopathy was compared in male wild type (WT) or disulfide-resistant C42S PKG Iα knock-in (KI) mice. Echocardiography showed that doxorubicin treatment caused loss of myocardial tissue and depressed left ventricular function in WT mice. Doxorubicin also reduced pro-survival signaling and increased apoptosis in WT hearts. In contrast, KI mice were markedly resistant to the dysfunction induced by doxorubicin in WTs. In follow-on experiments the influence of the PDE5 inhibitor tadalafil on the development of doxorubicin-induced cardiomyopathy in WT and KI mice was investigated. In WT mice, co-administration of tadalafil with doxorubicin reduced PKG Iα oxidation caused by doxorubicin and also protected against cardiac injury and loss of function. KI mice were again innately resistant to doxorubicin-induced cardiotoxicity, and therefore tadalafil afforded no additional protection. Doxorubicin decreased phosphorylation of RhoA (Ser-188), stimulating its GTPase activity to activate Rho-associated protein kinase (ROCK) in WTs. These pro-apoptotic events were absent in KI mice and were attenuated in WTs co-administered tadalafil. PKG Iα disulfide formation triggers cardiac injury, and this initiation of maladaptive signaling can be blocked by pharmacological therapies that elevate cGMP, which binds kinase to limit its oxidation.


Asunto(s)
Cardiomegalia , Proteína Quinasa Dependiente de GMP Cíclico Tipo I , Disulfuros/metabolismo , Doxorrubicina , Insuficiencia Cardíaca , Inhibidores de Fosfodiesterasa 5/farmacología , Sistemas de Mensajero Secundario , Tadalafilo/farmacología , Animales , Cardiomegalia/inducido químicamente , Cardiomegalia/enzimología , Cardiomegalia/genética , Cardiomegalia/prevención & control , GMP Cíclico/genética , GMP Cíclico/metabolismo , Proteína Quinasa Dependiente de GMP Cíclico Tipo I/antagonistas & inhibidores , Proteína Quinasa Dependiente de GMP Cíclico Tipo I/genética , Proteína Quinasa Dependiente de GMP Cíclico Tipo I/metabolismo , Fosfodiesterasas de Nucleótidos Cíclicos Tipo 5/genética , Fosfodiesterasas de Nucleótidos Cíclicos Tipo 5/metabolismo , Doxorrubicina/efectos adversos , Doxorrubicina/farmacología , Insuficiencia Cardíaca/inducido químicamente , Insuficiencia Cardíaca/enzimología , Insuficiencia Cardíaca/genética , Insuficiencia Cardíaca/prevención & control , Ratones , Ratones Mutantes , Oxidación-Reducción , Sistemas de Mensajero Secundario/efectos de los fármacos , Sistemas de Mensajero Secundario/genética , Quinasas Asociadas a rho/genética , Quinasas Asociadas a rho/metabolismo
3.
Proteomics ; 14(10): 1130-40, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24644084

RESUMEN

Pilot Project #1--the identification and characterization of human histone H4 proteoforms by top-down MS--is the first project launched by the Consortium for Top-Down Proteomics (CTDP) to refine and validate top-down MS. Within the initial results from seven participating laboratories, all reported the probability-based identification of human histone H4 (UniProt accession P62805) with expectation values ranging from 10(-13) to 10(-105). Regarding characterization, a total of 74 proteoforms were reported, with 21 done so unambiguously; one new PTM, K79ac, was identified. Inter-laboratory comparison reveals aspects of the results that are consistent, such as the localization of individual PTMs and binary combinations, while other aspects are more variable, such as the accurate characterization of low-abundance proteoforms harboring >2 PTMs. An open-access tool and discussion of proteoform scoring are included, along with a description of general challenges that lie ahead including improved proteoform separations prior to mass spectrometric analysis, better instrumentation performance, and software development.


Asunto(s)
Proteómica/métodos , Cromatografía Liquida/métodos , Análisis por Conglomerados , Células HeLa , Histonas/análisis , Histonas/química , Humanos , Espectrometría de Masas/métodos , Proyectos Piloto , Procesamiento Proteico-Postraduccional , Programas Informáticos
4.
Anal Chem ; 85(19): 9164-72, 2013 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-24040747

RESUMEN

We report the reliable determination of equilibrium protein disulfide bond reduction potentials (E°') by isotope-coded cysteine alkylation coupled with top-down Fourier transform ion cyclotron resonance mass spectrometry (FTICR MS). This technique enables multiple redox-active sites to be characterized simultaneously and unambiguously without the need for proteolysis or site-directed mutagenesis. Our model system was E. coli thioredoxin, and we determined E°' for its CGPC active-site disulfide as -280 mV in accord with literature values. E°' for the homologous disulfide in human thioredoxin 1 (Trx1) was determined as -281 mV, a value considerably more negative than the previously reported -230 mV. We also observed S-glutathionylation of Trx1 and localized that redox modification to Cys72; E°' for the intermolecular disulfide was determined as -186 mV. Intriguingly, that value corresponds to the intracellular glutathione/glutathione disulfide (GSH/GSSG) potential at the redox boundary between cellular differentiation and apoptosis.


Asunto(s)
Ciclotrones , Disulfuros/química , Análisis de Fourier , Tiorredoxinas/química , Dominio Catalítico , Escherichia coli , Humanos , Espectrometría de Masas , Oxidación-Reducción
5.
Anal Biochem ; 420(1): 96-8, 2012 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-21964498

RESUMEN

Oxidation of cysteine is now known to serve as a fundamental mechanism to control protein function or activity. Many redox-regulated proteins do not oxidize to homogeneity, resulting in a mixture of reduced and oxidized species which cannot be separated chromatographically. Here we describe a protocol for the separation of reduced and oxidized forms of the tumor suppressor protein p53. This purification method relies on the reversible labeling of thiol groups with biotin and exploitation of the ultrastrong biotin-avidin interaction. This purification procedure can be applied to other cysteine-containing proteins where enrichment of the oxidized form is required.


Asunto(s)
Cromatografía de Afinidad/métodos , Proteína p53 Supresora de Tumor/aislamiento & purificación , Proteína p53 Supresora de Tumor/metabolismo , Avidina/química , Biotina/química , Cisteína/química , Humanos , Oxidación-Reducción , Compuestos de Sulfhidrilo/química
6.
Expert Rev Proteomics ; 7(1): 19-20, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20121472

RESUMEN

The beautiful scenery around Ardgour in the North West of Scotland was the setting for the sixth annual Exploratory Measurement Science Group symposium. The meeting was organized as a study retreat for scientists with an interest in applications of mass spectrometry and associated technologies to discuss ideas in a relaxed, informal setting. Speakers were invited from a wide range of subject areas in the general field of mass spectrometry technology development and application.


Asunto(s)
Espectrometría de Masas , Biología Molecular , Nanotecnología , Proteómica , Escocia , Programas Informáticos
7.
Sci Rep ; 7(1): 9938, 2017 08 30.
Artículo en Inglés | MEDLINE | ID: mdl-28855531

RESUMEN

Despite the mechanisms for endogenous nitroxyl (HNO) production and action being incompletely understood, pharmacological donors show broad therapeutic promise and are in clinical trials. Mass spectrometry and site-directed mutagenesis showed that chemically distinct HNO donors 1-nitrosocyclohexyl acetate or Angeli's salt induced disulfides within cGMP-dependent protein kinase I-alpha (PKGIα), an interdisulfide between Cys42 of the two identical subunits of the kinase and a previously unobserved intradisulfide between Cys117 and Cys195 in the high affinity cGMP-binding site. Kinase activity was monitored in cells transfected with wildtype (WT), Cys42Ser or Cys117/195Ser PKGIα that cannot form the inter- or intradisulfide, respectively. HNO enhanced WT kinase activity, an effect significantly attenuated in inter- or intradisulfide-deficient PKGIα. To investigate whether the intradisulfide modulates cGMP binding, real-time imaging was performed in vascular smooth muscle cells expressing a FRET-biosensor comprising the cGMP-binding sites of PKGIα. HNO induced FRET changes similar to those elicited by an increase of cGMP, suggesting that intradisulfide formation is associated with activation of PKGIα. Intradisulfide formation in PKGIα correlated with enhanced HNO-mediated vasorelaxation in mesenteric arteries in vitro and arteriolar dilation in vivo in mice. HNO induces intradisulfide formation in PKGIα, inducing the same effect as cGMP binding, namely kinase activation and thus vasorelaxation.


Asunto(s)
Proteína Quinasa Dependiente de GMP Cíclico Tipo I/química , Proteína Quinasa Dependiente de GMP Cíclico Tipo I/metabolismo , GMP Cíclico/metabolismo , Disulfuros/metabolismo , Mutagénesis Sitio-Dirigida , Óxidos de Nitrógeno/farmacología , Animales , Dominio Catalítico , Células Cultivadas , Proteína Quinasa Dependiente de GMP Cíclico Tipo I/genética , Cisteína/genética , Transferencia Resonante de Energía de Fluorescencia , Células HEK293 , Humanos , Masculino , Espectrometría de Masas , Ratones , Músculo Liso Vascular/citología , Músculo Liso Vascular/metabolismo , Oxidación-Reducción
8.
Nat Commun ; 7: 13187, 2016 10 26.
Artículo en Inglés | MEDLINE | ID: mdl-27782102

RESUMEN

The Frank-Starling mechanism allows the amount of blood entering the heart from the veins to be precisely matched with the amount pumped out to the arterial circulation. As the heart fills with blood during diastole, the myocardium is stretched and oxidants are produced. Here we show that protein kinase G Iα (PKGIα) is oxidant-activated during stretch and this form of the kinase selectively phosphorylates cardiac phospholamban Ser16-a site important for diastolic relaxation. We find that hearts of Cys42Ser PKGIα knock-in (KI) mice, which are resistant to PKGIα oxidation, have diastolic dysfunction and a diminished ability to couple ventricular filling with cardiac output on a beat-to-beat basis. Intracellular calcium dynamics of ventricular myocytes isolated from KI hearts are altered in a manner consistent with impaired relaxation and contractile function. We conclude that oxidation of PKGIα during myocardial stretch is crucial for diastolic relaxation and fine-tunes the Frank-Starling response.


Asunto(s)
Proteína Quinasa Dependiente de GMP Cíclico Tipo I/genética , Diástole/fisiología , Ventrículos Cardíacos/enzimología , Miocardio/enzimología , Miocitos Cardíacos/enzimología , Animales , Fenómenos Biomecánicos , Calcio/metabolismo , Proteínas de Unión al Calcio/genética , Proteínas de Unión al Calcio/metabolismo , Gasto Cardíaco/fisiología , Proteína Quinasa Dependiente de GMP Cíclico Tipo I/metabolismo , Disulfuros/química , Perfilación de la Expresión Génica , Regulación de la Expresión Génica , Técnicas de Sustitución del Gen , Ventrículos Cardíacos/citología , Masculino , Ratones , Ratones Endogámicos C57BL , Contracción Miocárdica/fisiología , Miocardio/citología , Miocitos Cardíacos/citología , Técnicas de Cultivo de Órganos , Oxidación-Reducción , Estrés Oxidativo , Fosforilación , Cultivo Primario de Células , Serina/metabolismo , Especificidad por Sustrato
9.
Hypertension ; 64(6): 1344-51, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25267801

RESUMEN

Dysregulated blood pressure control leading to hypertension is prevalent and is a risk factor for several common diseases. Fully understanding blood pressure regulation offers the possibility of developing rationale therapies to alleviate hypertension and associated disease risks. Although hydrogen sulfide (H2S) is a well-established endogenous vasodilator, the molecular basis of its blood-pressure lowering action is incompletely understood. H2S-dependent vasodilation and blood pressure lowering in vivo was mediated by it catalyzing formation of an activating interprotein disulfide within protein kinase G (PKG) Iα. However, this oxidative activation of PKG Iα is counterintuitive because H2S is a thiol-reducing molecule that breaks disulfides, and so it is not generally anticipated to induce their formation. This apparent paradox was explained by H2S in the presence of molecular oxygen or hydrogen peroxide rapidly converting to polysulfides, which have oxidant properties that in turn activate PKG by inducing the disulfide. These observations are relevant in vivo because transgenic knockin mice in which the cysteine 42 redox sensor within PKG has been systemically replaced with a redox-dead serine residue are resistant to H2S-induced blood pressure lowering. Thus, a primary mechanism by which the reductant molecule H2S lowers blood pressure is mediated somewhat paradoxically by the oxidative activation of PKG.


Asunto(s)
Presión Sanguínea/efectos de los fármacos , Proteína Quinasa Dependiente de GMP Cíclico Tipo I/metabolismo , Sulfuro de Hidrógeno/farmacología , Hipertensión/tratamiento farmacológico , Animales , Modelos Animales de Enfermedad , Hipertensión/metabolismo , Hipertensión/fisiopatología , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Sustancias Reductoras
10.
J Am Soc Mass Spectrom ; 25(4): 636-50, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24496597

RESUMEN

We assemble a versatile molecular scaffold from simple building blocks to create binary and multiplexed stable isotope reagents for quantitative mass spectrometry. Termed Protected Amine Labels (PAL), these reagents offer multiple analytical figures of merit including, (1) robust targeting of peptide N-termini and lysyl side chains, (2) optimal mass spectrometry ionization efficiency through regeneration of primary amines on labeled peptides, (3) an amino acid-based mass tag that incorporates heavy isotopes of carbon, nitrogen, and oxygen to ensure matched physicochemical and MS/MS fragmentation behavior among labeled peptides, and (4) a molecularly efficient architecture, in which the majority of hetero-atom centers can be used to synthesize a variety of nominal mass and sub-Da isotopologue stable isotope reagents. We demonstrate the performance of these reagents in well-established strategies whereby up to four channels of peptide isotopomers, each separated by 4 Da, are quantified in MS-level scans with accuracies comparable to current commercial reagents. In addition, we utilize the PAL scaffold to create isotopologue reagents in which labeled peptide analogs differ in mass based on the binding energy in carbon and nitrogen nuclei, thereby allowing quantification based on MS or MS/MS spectra. We demonstrate accurate quantification for reagents that support 6-plex labeling and propose extension of this scheme to 9-channels based on a similar PAL scaffold. Finally, we provide exemplar data that extend the application of isotopologe-based quantification reagents to medium resolution, quadrupole time-of-flight mass spectrometers.


Asunto(s)
Aminas/química , Péptidos/química , Proteómica/métodos , Espectrometría de Masas en Tándem/métodos , Médula Ósea , Análisis de Fourier , Humanos , Indicadores y Reactivos/química , Marcaje Isotópico , Péptidos/análisis , Unión Proteica , Proteoma/análisis , Proteoma/química , Transducción de Señal
11.
J Am Soc Mass Spectrom ; 22(5): 888-97, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21472523

RESUMEN

The tumor suppressor p53 is a redox-regulated transcription factor involved in cell cycle arrest, apoptosis and senescence in response to multiple forms of stress, as well as many other cellular processes such as DNA repair, glycolysis, autophagy, oxidative stress and differentiation. The discovery of cysteine-targeting compounds that cause re-activation of mutant p53 and the death of tumor cells in vivo has emphasized the functional importance of p53 thiols. Using a combination of top-down and middle-down FTICR mass spectrometry, we show that of the 10 Cys residues in the core domain of wild-type p53, Cys182 and Cys277 exhibit a remarkable preference for modification by the alkylating reagent N-ethylmaleimide. The assignment of Cys182 and Cys277 as the two reactive Cys residues was confirmed by site-directed mutagenesis. Further alkylation of p53 beyond Cys182 and Cys277 was found to trigger co-operative modification of the remaining seven Cys residues and protein unfolding. This study highlights the power of top-down FTICR mass spectrometry for analysis of the cysteine reactivity and redox chemistry in multiple cysteine-containing proteins.


Asunto(s)
Cisteína/química , Espectrometría de Masas/métodos , Proteína p53 Supresora de Tumor/química , Alquilantes , Secuencia de Aminoácidos , Cristalografía por Rayos X , Cisteína/metabolismo , Etilmaleimida , Análisis de Fourier , Humanos , Modelos Moleculares , Datos de Secuencia Molecular , Oxidación-Reducción , Fragmentos de Péptidos/química , Fragmentos de Péptidos/metabolismo , Desplegamiento Proteico , Temperatura , Proteína p53 Supresora de Tumor/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA